Featured Content

Free Content

CLINICAL TRIAL

Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator’s Global Assessment: a pooled analysis of data from two phase III trials (Page 80 - 87)

Enlarge

Figure 1

Enlarge

Figure 2

Enlarge

Figure 3

Commentary or Editorial available

Media

YouTube

0

Login to favourite Read & Respond

CLINICAL TRIAL

Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate‐to‐severe plaque psoriasis: results from a randomized phase II study (Page 88 - 95)

Enlarge

Figure 1

Enlarge

Figure 2

Enlarge

Figure 3

0

Login to favourite Read & Respond

Just Published

Research Letters

Concurrent mucous membrane pemphigoid and membranous glomerulonephritis in a patient with autoantibodies targeting the 1080 region of collagen XVII

0

Login to favourite Read & Respond

Research Letters

Single‐agent taxane is useful in palliative chemotherapy for advanced extramammary Paget disease: a case series

0

Login to favourite Read & Respond

Research Letters

Features of cutaneous acute graft‐versus‐host disease by reflectance confocal microscopy

0

Login to favourite Read & Respond

General Dermatology

Eczema apps conformance with clinical guidelines: a systematic assessment of functions, tools and content

0

Login to favourite Read & Respond

General dermatology

The optimal oral biopsy site for diagnosis of mucous membrane pemphigoid and pemphigus vulgaris

0

Login to favourite Read & Respond

Research Letters

Naegeli–Franceschetti–Jadassohn syndrome and dermatopathia pigmentosa reticularis: intrafamilial overlap of phenotypes in patients with the same KRT 14 frameshift variant

0

Login to favourite Read & Respond

Perspectives

Benefits to patient care of electronically capturing patient‐reported outcomes in dermatology

0

Login to favourite Read & Respond

Systematic Review

Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta‐analysis

0

Login to favourite Read & Respond

Review Articles

Primary paediatric cutaneous mucinoses

Media

bjd18004-sup-0003-final.pptx

0

Login to favourite Read & Respond

Letters to the Editor

The conchal bowl donor site for full‐thickness skin graft reconstruction of nasal ala surgical defects: a comprehensive review, approach and outcomes of 81 cases over 10 years

0

Login to favourite Read & Respond
View all original articles

Case Reports

THERAPY

Talimogene laherparepvec (T‐VEC ) in advanced melanoma: complete response in a heart and kidney transplant patient. A case report

Commentary or Editorial available

Media

bjd17783-sup-0001-PowerpointS1.pptx

0

Login to favourite Read & Respond
Free Content

THERAPY

Dramatic response to brentuximab vedotin in refractory nontransformed CD 30 mycosis fungoides allowing allogeneic stem cell transplant and long‐term complete remission

Commentary or Editorial available

0

Login to favourite Read & Respond

What's New

@BrJDermatol

16 Jul 2019

RT UoM Open Access+ @UoMOpenAccess: 🔓Psychiatric morbidity and suicidal behaviour in psoriasis: a primary care cohort study, published in @BrJDermatol, is now #OpenAccess via https://t.co/GvxVgOGot0 @UoMPharmaOpt @dataevan @hayley_gorton @meds_safety @NCAresearchNHS @s9tmt @PSTRC_GM @Ezzoef @paryaneh @ZZNYiu https://t.co/WdrxCjn78H

@BrJDermatol

15 Jul 2019

RT The British Association of Dermatologists @HealthySkin4All: The authors of this @BrJDermatol study concluded their results clearly demonstrate that risankizumab is more effective than ustekinumab for treating psoriasis, though more work needs to be done to identify why this is the case. https://t.co/2oOpZKgFwp @Wiley_Health @PsoriasisUK

@BrJDermatol

15 Jul 2019

Do you think it is time to get rid of the the Investigator's Global Assessment as the primary outcome for clinical trials in #AtopicDermatitis? Read this thought-provoking commentary in this month's @BrJDermatol and tell us what you think: https://t.co/pXFZpph8Kr https://t.co/M80N5umTAC

@BrJDermatol

15 Jul 2019

RT Álvaro González-Cantero @Alvaro_Gonza: ➡️Check out this interesting article published in @BrJDermatol on the management of psoriasis as a systemic disease. ➡️It includes reference to our work on Psoriasis and Arterial Ultrasound 😊 #psoriasis #research #dermatology #dermatogia https://t.co/c8XeZflbsp https://t.co/1LpLvv43Tj

@BrJDermatol

15 Jul 2019

RT Pauline Nelson @DrP_Manc: One of our 10 excellent papers in @BrJDermatol 2nd Spotlight on Qualitative Methods Check out our editorial to get a taste of the rest #BJDQualitativeResearch #Dermatology https://t.co/Pbn8dbZ1Sq https://t.co/5gEatXjOse

@BrJDermatol

15 Jul 2019

RT The British Association of Dermatologists @HealthySkin4All: Many people who received melanoma genetic risk information reacted positively to the information and a number of participants said it had changed their behaviour in the sun for the better. https://t.co/tj4ag5hDFf @BrJDermatol @Wiley_Health @WileyNews https://t.co/KlXZWQ02xZ

View more
Close